News
-
-
-
COMMUNIQUÉ DE PRESSE
Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors
Andera Partners co-leads $196 million financing round for Kestra Medical, appoints Raymond W. Cohen to the board. Kestra develops a wearable defibrillator vest for cardiac patients -
-
-
COMMUNIQUÉ DE PRESSE
Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences
Andera Partners' portfolio company JenaValve Technology acquired by Edwards Lifesciences, marking a significant milestone in cardiovascular innovation with FDA approval expected by late 2025 -
-
-
COMMUNIQUÉ DE PRESSE
Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones
Andera Partners' portfolio company TRiCares secures $50 million in Series D Financing to support upcoming clinical milestones for its tricuspid heart valve replacement system, Topaz -
